Author: Jue Andrea
Publisher: Informa Healthcare
ISSN: 0882-0538
Source: Seminars in Ophthalmology, Vol.24, Iss.2, 2009-03, pp. : 122-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The use of bevacizumab for the treatment of proliferative diabetic retinopathy, neovascular glaucoma, neovascular age related macular degeneration, and cystoid macular edema has been extensively reported upon. From the published case reports available, bevacizumab may be a useful adjunct to the trabeculectomy procedure.
Related content
Use of Mitomycin C in Primary Trabeculectomy
By Beiran Itzchak Mezer Eedy Tamir Ada Scharf Jehudith Miller Benjamin
Annals of Ophthalmology, Vol. 34, Iss. 2, 2002-06 ,pp. :
Management of Bleb Complications after Trabeculectomy
By Leung Dexter Y. L. Tham Clement C. Y.
Seminars in Ophthalmology, Vol. 28, Iss. 3, 2013-05 ,pp. :